tiprankstipranks
Trending News
More News >
InDex Pharmaceuticals Holding AB (SE:FLERIE)
:FLERIE
US Market

InDex Pharmaceuticals Holding AB (FLERIE) Ratios

Compare
1 Followers

InDex Pharmaceuticals Holding AB Ratios

SE:FLERIE's free cash flow for Q4 2025 was kr―. For the 2025 fiscal year, SE:FLERIE's free cash flow was decreased by kr and operating cash flow was kr―. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
0.00 55.39 5.04 23.57
Quick Ratio
0.00 55.39 5.04 23.57
Cash Ratio
58.03 46.76 5.00 23.41
Solvency Ratio
-20.83 -8.99 -1.55 -5.71
Operating Cash Flow Ratio
-1.99 -0.92 -0.64 -8.78
Short-Term Operating Cash Flow Coverage
-43.75 -42.50 0.00 0.00
Net Current Asset Value
kr -13.40Mkr ―kr 999.40Mkr 236.11Mkr 329.97M
Leverage Ratios
Debt-to-Assets Ratio
<0.01 <0.01 <0.01 <0.01
Debt-to-Equity Ratio
<0.01 <0.01 <0.01 <0.01
Debt-to-Capital Ratio
<0.01 <0.01 <0.01 <0.01
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00
Financial Leverage Ratio
1.00 1.01 1.25 1.05
Debt Service Coverage Ratio
-4.20 -53.81 -413.31 -826.23
Interest Coverage Ratio
-2.69 -29.16 -472.98 -1.26K
Debt to Market Cap
<0.01 <0.01 0.00 0.00
Interest Debt Per Share
1.15 0.07 0.05 0.06
Net Debt to EBITDA
1.37 3.83 3.11 3.45
Profitability Margins
Gross Profit Margin
-102.86%-41600.00%95.74%0.00%
EBIT Margin
-5348.57%-226500.00%-97.47%0.00%
EBITDA Margin
-5335.71%-225900.00%-96.22%0.00%
Operating Profit Margin
-3405.71%-110800.00%-110.11%0.00%
Pretax Profit Margin
-3988.57%-227900.00%-97.70%0.00%
Net Profit Margin
-4000.00%-228000.00%-97.70%0.00%
Continuous Operations Profit Margin
-4000.00%-228000.00%-97.70%0.00%
Net Income Per EBT
100.29%100.04%100.00%100.00%
EBT Per EBIT
117.11%205.69%88.73%66.40%
Return on Assets (ROA)
-7.12%-5.40%-31.82%-28.56%
Return on Equity (ROE)
-6.92%-5.43%-39.88%-30.04%
Return on Capital Employed (ROCE)
-6.08%-2.64%-44.65%-44.89%
Return on Invested Capital (ROIC)
2838.10%-2.63%-44.52%-44.81%
Return on Tangible Assets
-7.12%-5.40%-31.82%-28.56%
Earnings Yield
-9.69%-6.89%-3.32%-3.50%
Efficiency Ratios
Receivables Turnover
0.02 <0.01 42.52 0.00
Payables Turnover
0.00 69.50 0.62 0.16
Inventory Turnover
0.00 0.00 0.00 0.00
Fixed Asset Turnover
11.67 0.10 35.16 0.00
Asset Turnover
<0.01 <0.01 0.33 0.00
Working Capital Turnover Ratio
0.01 <0.01 0.34 0.00
Cash Conversion Cycle
16.69K 539.10K -583.42 -2.25K
Days of Sales Outstanding
16.69K 539.11K 8.58 0.00
Days of Inventory Outstanding
0.00 0.00 0.00 0.00
Days of Payables Outstanding
0.00 5.25 592.01 2.25K
Operating Cycle
16.69K 539.11K 8.58 0.00
Cash Flow Ratios
Operating Cash Flow Per Share
-0.23 -0.24 -0.71 -2.43
Free Cash Flow Per Share
-0.23 -0.24 -0.71 -2.43
CapEx Per Share
0.00 0.00 0.00 0.00
Free Cash Flow to Operating Cash Flow
1.00 1.00 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
0.00 0.00 0.00 0.00
Capital Expenditure Coverage Ratio
0.00 0.00 0.00 0.00
Operating Cash Flow Coverage Ratio
-35.00 -21.25 -16.53 -39.80
Operating Cash Flow to Sales Ratio
-2.50 -170.00 -0.39 0.00
Free Cash Flow Yield
-0.61%-0.51%-1.33%-4.52%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-10.32 -14.51 -30.08 -28.56
Price-to-Sales (P/S) Ratio
411.07 33.09K 29.39 0.00
Price-to-Book (P/B) Ratio
0.74 0.79 12.00 8.58
Price-to-Free Cash Flow (P/FCF) Ratio
-164.43 -194.62 -75.46 -22.14
Price-to-Operating Cash Flow Ratio
-165.08 -194.62 -75.46 -22.14
Price-to-Earnings Growth (PEG) Ratio
1.22 0.18 5.90 2.46
Price-to-Fair Value
0.74 0.79 12.00 8.58
Enterprise Value Multiple
-6.34 -10.82 -27.43 -25.46
Enterprise Value
2.37B 2.44B 2.57B 2.52B
EV to EBITDA
-6.34 -10.82 -27.43 -25.46
EV to Sales
338.18 24.44K 26.40 0.00
EV to Free Cash Flow
-135.27 -143.78 -67.78 -19.50
EV to Operating Cash Flow
-135.27 -143.78 -67.78 -19.50
Tangible Book Value Per Share
50.38 59.57 4.48 6.27
Shareholders’ Equity Per Share
50.38 59.57 4.48 6.27
Tax and Other Ratios
Effective Tax Rate
>-0.01 >-0.01 0.00 0.00
Revenue Per Share
0.09 <0.01 1.83 0.00
Net Income Per Share
-3.60 -3.24 -1.79 -1.88
Tax Burden
1.00 1.00 1.00 1.00
Interest Burden
0.75 1.01 1.00 1.00
Research & Development to Revenue
0.00 0.00 0.00 0.00
SG&A to Revenue
0.00 69.00 0.00 0.00
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00
Income Quality
0.06 0.07 0.40 1.29
Currency in SEK